- Exchange: Frankfurt
- Sector: Consumer, Non-cyclical
- Industry: Biotechnology
- Sub-Industry: Medical-Biomedical/Gene
Snapshot for Agenus Inc (AJ81)
| Open: | 3.141 | Day's Range: | 3.141 - 3.141 | Volume: | 0 |
|---|---|---|---|---|---|
| Previous Close: | 3.084 | 52wk Range: | 2.666 - 4.645 | 1-Yr Rtn: | -23.46% |
Key Statistics for AJ81
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(12/2013) | - |
| Relative P/E vs. DAX | - |
| Earnings Per Share (USD) (ttm) | - |
| Est. EPS (USD) (12/2013) | -0.9770 |
| Est. PEG Ratio | - |
| Market Cap (M EUR) | 0.00 |
| Shares Outstanding (M) | 0.00 |
| 30 Day Average Volume | 241 |
| Price/Book (mrq) | - |
| Price/Sale (ttm) | - |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 08/02/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for AJ81
Company Profile & Key Executives for AJ81
Agenus, Inc. develops vaccines. The Company researches vaccines for brain cancer, kidney cancer, herpes, lung cancer, melanoma, malaria, shingles, and Alzheimer's disease.
| Garo H ArmenChairman/CEO/Co-Founder | Karen H ValentineVP/Chief Compliance Ofcr/Secy |
| Kerry A WentworthVP:Clinical & Regulatory | Christine M KlaskinVP:Finance |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
AJ81 News
-
Industry News
Advertisement
- 1
- 2
- 3
- 4
- 5
Advertisement
Sponsored Links
Advertisements
Rate this Page